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Background
Juvenile idiopathic arthritis (JIA) is the most common
inflammatory arthritis of childhood. Its association with
familial Mediterranean fever (FMF) had been reported
previously, but it is not known how presence of FMF affect
presentation and outcome of JIA.
Aim
To identify the effect of FMF on the presentation and out-
come of JIA both clinically and in laboratory values.
Patients and methods
Thirty-two patients diagnosed as JIA according to ILAR cri-
teria and FMF according to Tel-Hashomer criteria with
heterozygous or homozygous for MEFV mutations were
enrolled to the study. The control group consisted 32 JIA
patients without FMF. Their data were analysed retrospec-
tively from their follow-up charts.
Results
The gender, age, age of onset, age at the time of diagnosis
and subgroups of JIA were similar in both groups. At the
first presentation sedimentation rates, leukocyte counts,
affected number of joints, frequency of uveitis and hip
involvements were also similar among the groups. But the
CRP levels, frequency of sacroileitis and the number of
drugs used during treatment of the patients with the diag-
nosis of JIA and FMF was significantly higher than the
controls (p < 0.05).
Conclusion
It was believed that MEFV mutations increase the level of
inflammation, we have shown a marked difference in CRP
levels, frequency of sacroileitis and the number of drugs
needed to control the disease. This study may be a clue for
new studies using more standardized outcome measures
in large cohorts.
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